CiToxLAB Group:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:CiToxLAB Group - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10681
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CiToxLab Group (CiToxLab) is a contract research organization that provides preclinical and specialty services. The company provides toxicology and safety pharmacology, biomarkers, pharmacokinetics, immunology services, surgical models and medical device implantation, animal efficacy models, preclinical and clinical genomics and biodistribution services. CiToxLab also offers support services for the development of candidate pharmaceuticals and biopharmaceuticals in the areas of biologicals, hormones, small molecules, vaccines, gene therapy vectors, biosimilars and others. The company caters its services to pharmaceutical, chemicals, food, cosmetics, biotechnology and medical devices companies. It has a presence in France, Denmark, Hungary and North America. CiToxLab is headquartered in Evreux, France.

CiToxLAB Group – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CiToxLAB Group, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CiToxLAB Group, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CiToxLAB Group, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CiToxLAB Group, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CiToxLAB Group, Medical Devices Deals, 2012 to YTD 2018 9
CiToxLAB Group, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
CiToxLAB Group, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
CiToxLAB Acquires New Facility for Bioanalysis and Biomarkers Services 11
Partnerships 12
Citoxlab Enters into Partnership with Experimental Pharmacology and Oncology Berlin-Buch 12
Acquisition 13
Citoxlab to Acquire Solvo Biotech 13
CiToxLAB Acquires Xenometrics 14
CiToxLAB Acquires AccelLAB 15
CiToxLAB Group – Key Competitors 16
CiToxLAB Group – Key Employees 17
CiToxLAB Group – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Corporate Communications 19
Aug 30, 2018: Citoxlab names Christophe Berthoux as CEO, Europe 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
CiToxLAB Group, Pharmaceuticals & Healthcare, Key Facts 2
CiToxLAB Group, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CiToxLAB Group, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CiToxLAB Group, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CiToxLAB Group, Deals By Therapy Area, 2012 to YTD 2018 8
CiToxLAB Group, Medical Devices Deals, 2012 to YTD 2018 9
CiToxLAB Group, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
CiToxLAB Acquires New Facility for Bioanalysis and Biomarkers Services 11
Citoxlab Enters into Partnership with Experimental Pharmacology and Oncology Berlin-Buch 12
Citoxlab to Acquire Solvo Biotech 13
CiToxLAB Acquires Xenometrics 14
CiToxLAB Acquires AccelLAB 15
CiToxLAB Group, Key Competitors 16
CiToxLAB Group, Key Employees 17
CiToxLAB Group, Other Locations 18
CiToxLAB Group, Subsidiaries 18

List of Figures
CiToxLAB Group, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CiToxLAB Group, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CiToxLAB Group, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
CiToxLAB Group, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
CiToxLAB Group, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CiToxLAB Group, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
CiToxLAB Group, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CiToxLAB Group, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CiToxLAB Group, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[CiToxLAB Group:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Roquette Freres SA:企業の戦略的SWOT分析
    Roquette Freres SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Moss Bros Group Plc (MOSB):企業の財務・戦略的SWOT分析
    Moss Bros Group Plc (MOSB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Rice University-製薬・医療分野:企業M&A・提携分析
    Summary Rice University is an educational service provider that provides graduate and undergraduate education programs and research services. The institute offers academic programs in the field of applied physics, cognitive sciences, computational science and engineering, environment, leadership, mi …
  • Hasbro, Inc. (HAS):企業の財務・戦略的SWOT分析
    Hasbro, Inc. (HAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • EnBW Energie Baden-Wurttemberg AG (EBK):企業の財務・戦略的SWOT分析
    EnBW Energie Baden-Wurttemberg AG (EBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • West Hertfordshire Hospitals NHS Trust:企業の戦略的SWOT分析
    West Hertfordshire Hospitals NHS Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Barco N.V.:企業の戦略・SWOT・財務情報
    Barco N.V. - Strategy, SWOT and Corporate Finance Report Summary Barco N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Shell Canada Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Shell Canada Ltd (Shell Canada) a subsidiary of Royal Dutch Shell plc is an integrated oil and gas company that offers upstream and downstream services. The company's upstream services include markets and trades natural gas and power and exploration and extraction of natural gas. Its downstr …
  • OBI Pharma Inc (4174):製薬・医療:M&Aディール及び事業提携情報
    Summary OBI Pharma Inc (OBI Pharma) is a biopharmaceutical company that develops therapies for the treatment of cancer and infectious diseases. The company’s products include adagloxad simolenin, an active immunotherapy which is intended for the treatment of metastatic breast cancer; and OBI-833, a …
  • Connected Energy:企業の戦略的SWOT分析
    Connected Energy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • OAO Tatneft:企業の戦略・SWOT・財務情報
    OAO Tatneft - Strategy, SWOT and Corporate Finance Report Summary OAO Tatneft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • AnaMar AB-製薬・医療分野:企業M&A・提携分析
    Summary AnaMar AB (AnaMar), a subsidiary of Koncentra Holding AB, discovers, develops and commercializes therapeutic strategies to treat debilitating inflammation, fibrosis and pain. The company develops drug candidates from several chemical classes that concentrates on the receptors and shows poten …
  • British American Tobacco (Malaysia) Berhad:戦略・SWOT・企業財務分析
    British American Tobacco (Malaysia) Berhad - Strategy, SWOT and Corporate Finance Report Summary British American Tobacco (Malaysia) Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Filinvest Development Corporation (FDC):企業の財務・戦略的SWOT分析
    Filinvest Development Corporation (FDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Faes Farma SA (FAE):企業の財務・戦略的SWOT分析
    Faes Farma SA (FAE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Bassett Furniture Industries Inc (BSET):企業の財務・戦略的SWOT分析
    Bassett Furniture Industries Inc (BSET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Perseus Mining Ltd:企業の戦略・SWOT・財務分析
    Perseus Mining Ltd - Strategy, SWOT and Corporate Finance Report Summary Perseus Mining Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Aldi Einkauf GmbH & Co oHG:企業の戦略・SWOT・財務情報
    Aldi Einkauf GmbH & Co oHG - Strategy, SWOT and Corporate Finance Report Summary Aldi Einkauf GmbH & Co oHG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Banco BPI SA:企業の戦略・SWOT・財務分析
    Banco BPI SA - Strategy, SWOT and Corporate Finance Report Summary Banco BPI SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Central Petroleum Ltd (CTP):企業の財務・戦略的SWOT分析
    Summary Central Petroleum Ltd (CPL) operates as an oil and gas company that offers exploration and development services. The company develops, produces, processes and markets hydrocarbons. It operates its oil and gas assets in Amadeus basin, Pedirka basin, Georgina basin, and Wiso basin. CPL’s Amade …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆